GIA
MYGN icon

GHP Investment Advisors’s Myriad Genetics MYGN Stock Holding History

GHP Investment Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52 Buy
+9
New +$41 ﹤0.01% 1338
2025
Q4 		– Sell
-175
Closed -$1.27K – 1004
2025
Q3 		$1.27K Hold
175
– – ﹤0.01% 874
2025
Q2 		$930 Hold
175
– – ﹤0.01% 888
2025
Q1 		$1.55K Hold
175
– – ﹤0.01% 860
2024
Q4 		$2.4K Hold
175
– – ﹤0.01% 876
2024
Q3 		$4.79K Hold
175
– – ﹤0.01% 805
2024
Q2 		$4.28K Hold
175
– – ﹤0.01% 789
2024
Q1 		$3.73K Hold
175
– – ﹤0.01% 723
2023
Q4 		$3.35K Hold
175
– – ﹤0.01% 726
2023
Q3 		$2.54K Hold
175
– – ﹤0.01% 834
2023
Q2 		$3.13K Hold
175
– – ﹤0.01% 801
2023
Q1 		$4.07K Sell
175
-885
-83% -$18K ﹤0.01% 789
2022
Q4 		$15.4K Hold
1,060
– – ﹤0.01% 613
2022
Q3 		$20K Hold
1,060
– – ﹤0.01% 576
2022
Q2 		$19K Hold
1,060
– – ﹤0.01% 584
2022
Q1 		$27K Buy
+1,060
New +$27.1K ﹤0.01% 570
2020
Q2 		– Sell
-87,727
Closed -$1.25M – 272
2020
Q1 		$1.25M Buy
87,727
+15,890
+22% +$336K 0.19% 150
2019
Q4 		$1.96M Buy
71,837
+6,300
+10% +$173K 0.21% 147
2019
Q3 		$1.88M Buy
65,537
+2,095
+3% +$61K 0.23% 132
2019
Q2 		$1.76M Sell
63,442
-543
-0.8% -$15.3K 0.21% 144
2019
Q1 		$2.12M Buy
63,985
+2,915
+5% +$88.7K 0.27% 125
2018
Q4 		$1.77M Buy
61,070
+2,289
+4% +$82.3K 0.27% 129
2018
Q3 		$2.7M Buy
58,781
+5,491
+10% +$244K 0.36% 89
2018
Q2 		$1.99M Buy
53,290
+2,305
+5% +$77.9K 0.28% 106
2018
Q1 		$1.51M Buy
50,985
+865
+2% +$29.3K 0.21% 141
2017
Q4 		$1.72M Buy
50,120
+1,410
+3% +$47.6K 0.24% 125
2017
Q3 		$1.76M Buy
48,710
+4,853
+11% +$138K 0.27% 116
2017
Q2 		$1.13M Buy
43,857
+10,010
+30% +$212K 0.18% 158
2017
Q1 		$650K Buy
33,847
+9,025
+36% +$160K 0.11% 200
2016
Q4 		$414K Buy
24,822
+3,138
+14% +$56.8K 0.08% 232
2016
Q3 		$446K Buy
21,684
+810
+4% +$20.5K 0.09% 217
2016
Q2 		$639K Buy
20,874
+620
+3% +$21.5K 0.14% 183
2016
Q1 		$758K Buy
20,254
+2,885
+17% +$109K 0.17% 158
2015
Q4 		$750K Buy
17,369
+2,245
+15% +$94.8K 0.18% 147
2015
Q3 		$567K Buy
15,124
+1,600
+12% +$56.8K 0.15% 167
2015
Q2 		$458K Sell
13,524
-1,016
-7% -$34.5K 0.11% 188
2015
Q1 		$515K Buy
14,540
+1,315
+10% +$47.1K 0.13% 170
2014
Q4 		$450K Buy
13,225
+370
+3% +$13.1K 0.12% 179
2014
Q3 		$496K Buy
12,855
+460
+4% +$17.2K 0.15% 159
2014
Q2 		$482K Hold
12,395
– – 0.14% 165
2014
Q1 		$424K Sell
12,395
-340
-3% -$10.5K 0.14% 174
2013
Q4 		$267K Buy
12,735
+35
+0.3% +$885 0.09% 216
2013
Q3 		$298K Hold
12,700
– – 0.11% 207
2013
Q2 		$341K Buy
+12,700
New +$368K 0.14% 172

Other funds holding MYGN

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
ICP
Impact Capital Partners Greenwood Village, Colorado $367M AUM 28.36% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return

GHP Investment Advisors's MYGN Position: Q2 2026 in Review

GHP Investment Advisors opened a new position in Myriad Genetics (MYGN) in Q2 2026: 9 shares worth $52. The stake represents ﹤0.01% of the portfolio and ranks #1338 among its holdings. This is a return to the name: GHP Investment Advisors previously reported a position in MYGN as recently as Q3 2025.

GHP Investment Advisors first reported a position in MYGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $2.7M in Q3 2018. 32 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • GHP Investment Advisors held 9 shares of Myriad Genetics worth $52 as of Q2 2026.
  • Myriad Genetics was a new GHP Investment Advisors position in Q2 2026.
  • Myriad Genetics made up ﹤0.01% of GHP Investment Advisors's portfolio in Q2 2026, its #1338 holding.
  • GHP Investment Advisors first reported a position in Myriad Genetics in Q2 2013 and has held it in 44 quarters since.
  • GHP Investment Advisors's Myriad Genetics position peaked at $2.7M in Q3 2018.
  • 32 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on GHP Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.